Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Update on US regulatory review of roxadustat in anaemia of chronic kidney disease
-
Imfinzi recommended for approval in the EU by CHMP for less-frequent, fixed-dose use in unresectable non-small cell lung cancer
-
Trastuzumab deruxtecan recommended for approval in the EU by CHMP for HER2-positive metastatic breast cancer
-
Trixeo Aerosphere approved in the EU for maintenance treatment of COPD
-
AstraZeneca to acquire Alexion, accelerating the Company's strategic and financial development
-
Enhertu continues to demonstrate durable responses with new data from DESTINY-Breast01 in HER2-positive metastatic breast cancer
-
AZD1222 Oxford Phase III trials interim analysis results published in The Lancet
-
Calquence data across four trials reinforces cardiovascular safety profile in patients with chronic lymphocytic leukaemia
-
Calquence shows long-term efficacy and tolerability at three years for patients with relapsed or refractory mantle cell lymphoma
-
AstraZeneca demonstrates growing leadership in breast cancer at SABCS with data from its innovative medicines and robust pipeline
Latest articles and press releases
All of our latest press releases and articles are available to explore
